Summary: Researchers report an increased risk of insomnia in people who suffer from asthma. Additionally, insomnia is also associated with worse control of the illness, depression and other health issues.
New research in CHEST shows insomnia is highly prevalent in adults with asthma, associated with adverse outcomes.
A team of researchers from the University of Pittsburgh has found that insomnia is highly prevalent in adults with asthma and is also associated with worse asthma control, depression and anxiety symptoms and other quality of life and health issues. The study results are published in the current issue of the journal CHEST.
Patients with asthma commonly report difficulty with sleep; however, the prevalence of insomnia and its relationship with asthma burden and quality of life is unknown. Asthma is a chronic respiratory condition in the lungs in which the airways become swollen or inflamed, causing difficulty in breathing from spasms in the muscles surrounding the airways as they try to keep the passageways open. The impact of insomnia on asthma control and asthma-related healthcare utilization has not previously been examined.
The research reports that:
Clinically significant insomnia was present in 37 percent of the participants with asthma.
Those with insomnia had a higher BMI, worse lung function and lower annual household income than those without insomnia.
Despite reporting no nighttime asthma symptoms that disturbed their sleep, almost 25 percent of participants met criteria for clinically significant insomnia.
Compared with those without insomnia, the study found participants with insomnia reported more frequent asthma-related healthcare use in the past 12 months.
Participants with insomnia had worse asthma control and asthma-specific quality of life and higher levels of depression and anxiety symptoms. These results suggest that adults with asthma who have insomnia disorder may be at increased risk for adverse outcomes.
The research shows that there is a significant impact of insomnia on asthma disease burden and well-being and states that evaluation and treatment of insomnia should be considered among patients with asthma. “Our results show that poor sleep may not be solely due to nighttime awakenings due to asthma symptoms but may represent comorbid insomnia,” said lead author Faith Luyster, PhD, “and that comorbid insomnia can significantly impact asthma outcomes including quality of life and healthcare utilization.”
While it was determined that insomnia is highly prevalent in those with asthma and is associated with adverse outcomes, further studies are needed to better understand the relationship between insomnia and asthma control. Prospective and interventional studies, such as implementing cognitive-behavioral treatment for insomnia, are recommended moving forward.
The complete report on this research can be found in the journal CHEST.
About this sleep research article
Source: Andrea Rodriguez – ACCP Image Source: NeuroscienceNews.com image is in the public domain. Original Research:Abstract for “Association Between Insomnia and Asthma Burden in the Severe Asthma Research Program (SARP) III” by Faith S. Luyster, PhD; Patrick J. Strollo, Jr., MD; Fernando Holguin, MD, MPH; Mario Castro, MD; Eleanor M. Dunican, MD; John Fahy, MD; Benjamin Gaston, MD; Elliot Israel, MD; Nizar N. Jarjour, MD; David T. Mauger, PhD; Wendy C. Moore, MD; Sally E. Wenzel, MD in Chest. Published online December 2016 doi:10.1016/j.chest.2016.09.020
Cite This NeuroscienceNews.com Article
[cbtabs][cbtab title=”MLA”]ACCP “Insomnia Prevalent in Asthmatics.” NeuroscienceNews. NeuroscienceNews, 8 December 2016. <https://neurosciencenews.com/asthma-insomnia-5714/>.[/cbtab][cbtab title=”APA”]ACCP (2016, December 8). Insomnia Prevalent in Asthmatics. NeuroscienceNew. Retrieved December 8, 2016 from https://neurosciencenews.com/asthma-insomnia-5714/[/cbtab][cbtab title=”Chicago”]ACCP “Insomnia Prevalent in Asthmatics.” https://neurosciencenews.com/asthma-insomnia-5714/ (accessed December 8, 2016).[/cbtab][/cbtabs]
Association Between Insomnia and Asthma Burden in the Severe Asthma Research Program (SARP) III
Background Sleep difficulties are commonly reported by patients with asthma; however, the prevalence of insomnia and its association with disease burden and well-being is unknown. We aimed to determine the prevalence of insomnia, defined as combined sleep-specific complaints with associated daytime symptoms, among a large sample of adults with asthma, and to compare well-being, asthma control, and asthma-related health care utilization in individuals with asthma and insomnia and those without insomnia.
Methods Baseline data from adults with physician-confirmed asthma enrolled in the Severe Asthma Research Program III was used for analyses (N = 714). Participants completed the Insomnia Severity Index (ISI), Asthma Control Test, Asthma Quality of Life Questionnaire, and Hospital Anxiety and Depression Scale.
Results Insomnia (ISI ≥ 10) was identified in 263 participants (37%). Presence of insomnia was associated with higher levels of depression and anxiety symptoms and poorer quality of life. Those with insomnia had a 2.4-fold increased risk for having not well-controlled asthma and a 1.5-fold increased risk for asthma-related health care utilization in the past year compared with those without insomnia.
Conclusions Insomnia is highly prevalent in asthma and is associated with adverse outcomes. Further studies are needed to gain a better understanding of the interaction between insomnia and asthma control.
“Association Between Insomnia and Asthma Burden in the Severe Asthma Research Program (SARP) III” by Faith S. Luyster, PhD; Patrick J. Strollo, Jr., MD; Fernando Holguin, MD, MPH; Mario Castro, MD; Eleanor M. Dunican, MD; John Fahy, MD; Benjamin Gaston, MD; Elliot Israel, MD; Nizar N. Jarjour, MD; David T. Mauger, PhD; Wendy C. Moore, MD; Sally E. Wenzel, MD in Chest. Published online December 2016 doi:10.1016/j.chest.2016.09.020